1. Scrip
  2. >>Archive

Medical Device Regulations

Changes to Swiss ordinances affecting devices

Amendments to two Swiss ordinances affecting the clinical testing, regulatory approval and marketing of medical devices in Switzerland came into effect on 1 September 20041. The ordinances - the MedicalDevicesOrdinance, MepV, SR 812.213, and the Clinical Trials of Therapeutic Products Ordinance, Vklin, SR 812.214.2 - are two of the regulations adopted in support of the Swiss Therapeutic Products Law (Heilmittelgesetz). They cover implants, instruments, medicinal equipment, in vitro diagnostics and materials for use with the above mentioned categories.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

Executives On The Move: Nine CEOs, Six CMOs And Three CFOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Novo Nordisk and Takeda, plus Nxera Pharma nabs chief commercial officer from AstraZeneca.

Will China’s Retaliatory Tariffs Galvanize Manufacturing Onshoring?

 
• By Dexter Jie Yan

China’s imposed large retaliatory tariffs on US pharmaceuticals on 10 April, but some domestic firms with in-licensed, US-origin assets were already moving to localized manufacturing.

Compounding Unlikely To Solve GLP-1 Affordable Access Issues

 
• By Alaric DeArment

The end of semaglutide and tirzepatide shortages means large-scale compounding is declining, ICER noted. But compounded versions – and the demand for them – are likely here to stay.